Company intelligence
Milestone Pharmaceuticals, Inc.
Headquartered in Montreal, with a growing subsidiary in Charlotte, NC
About Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a patient-centric commercial-stage biopharmaceutical company dedicated to bringing innovative cardiology products to market. Our lead product, CARDAMYST™ (etripamil), is FDA approved for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. We are also dedicated to the continued clinical investigation of etripamil as a treatment for atrial fibrillation with rapid ventricular rate (AFib-RVR). At Milestone, everything we do is with the patient in mind. To learn more, visit www.milestonepharma.com. Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/
Verified activity
Signals from Milestone Pharmaceuticals, Inc.
6 published signals
Presence & Recognition
Milestone Pharmaceuticals, Inc. is attending the upcoming Global Healthcare Conference hosted by Cantor Fitzgerald.
Reported by Milestone Pharmaceuticals, Inc.
Presence & Recognition
Milestone Pharmaceuticals, Inc. President and CEO Joe Oliveto will participate in a fireside chat at the upcoming Wells Fargo 21st Annual Healthcare Conference.
Reported by Milestone Pharmaceuticals, Inc.
Presence & Recognition
Milestone Pharmaceuticals, Inc. participated in the Wells Fargo Healthcare Conference on September 8 with a Fireside Chat with CEO Joe Oliveto.
Reported by Milestone Pharmaceuticals, Inc.
Presence & Recognition
Milestone Pharmaceuticals, Inc. participated in the H.C. Wainwright & Co., LLC Global Investment Conference on September 15 with a Fireside Chat with CEO Joe Oliveto.
Reported by Milestone Pharmaceuticals, Inc.
Presence & Recognition
Milestone Pharmaceuticals, Inc. participated in the Cantor Fitzgerald Global Healthcare Conference on September 10.
Reported by Milestone Pharmaceuticals, Inc.
Presence & Recognition
Milestone Pharmaceuticals, Inc. hosted a Back-to-School Drive benefiting students at Lebanon Road Elementary School.
Reported by Milestone Pharmaceuticals, Inc.